SPDR S&P Biotech ETF(XBI) Stock Price | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Robinhood, Roku And Shopify Are Among Top 10 Large-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
BenzingaMar 23 11:16 ET
Notable Healthcare Headlines for the Week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in Focus
Seeking AlphaMar 23 09:05 ET
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
BenzingaMar 22 03:23 ET
SPDR S&P Biotech ETF To Go Ex-Dividend On March 24th, 2025 With 0.00525 USD Dividend Per Share
Moomoo NewsMar 21 20:35 ET
Is AbbVie Gaining or Losing Market Support?
BenzingaMar 21 16:15 ET
Top 10 S&P 500 Performers of 2025 All Returned Over 20% as the Broader Index Struggles
Seeking AlphaMar 21 15:06 ET

Comments

iamiam

Mar 19 20:09

Update, 19 Mar

A big day today, J Powow speaks, and the dots get plotted 😆
I will start with QQQ/ND and VIX, and then I will move to individual stocks. I don't own these and don't necessarily recommend buying them. I use them as sentiment and market bias/direction indicators.
I will be upfront and say my bias is up. How high doesn't really matter to me. I don't own the MAG 7. I just want to see willing buyers. I'm not nieve and am hedged for downside. but I have been buying a lot of individual ...

+33

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?

35

5

2

MyTradeHunter

Mar 19 00:19

Issue #203 - Synthetic Stock on XBI (18.3.25)

Options Trading Newsletter Issue #203 from Substack.
SYNTHETIC Stock ON XBI
The SPDR S&P Biotech ETF (XBI) is an equal-weighted ETF that tracks the S&P Biotechnology Select Industry Index. Unlike market-cap-weighted ETFs, XBI gives equal exposure to small, mid, and large biotech stocks. This makes it more volatile compared to other biotech ETFs like IBB, which is more weighted toward large-cap biotech firms.
XBI Price Action Analysis
– XBI has been on...

12

1

2

74425369

Mar 10 19:40

INSIDER BUY ALERT: JANX

What happened: In recent weeks, $Janux Therapeutics (JANX.US)$ has seen significant insider buying, notably from RA Capital Management, which acquired shares worth approximately $25.3M.
Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges.
Key Developments:
📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...

1

MyTradeHunter

Mar 6 23:02

Issue #201 - Recycling IWM Strangle

from Substack MyTradeHunter Newsletter
Market Scorecard
Market is weak with NQ dropping more than 7% and ES more by 5%. On contrast HSI has remained strong in anticipation of positive news flows coming out from the CCP Meetings in China, ongoing.
Trade Scorecard
IBIT Call Ratio (Update)
IBIT has hit roller coaster with selloff to a low of $46.07. Price has since recovered to $51.44.
We closed the short call 57C on 27 February when IBIT hit lows of $46.90 for $0...

+3

4

1

Kim10

Jan 9 06:20

$SPDR S&P Biotech ETF (XBI.US)$ big bearish flow coming in looking like a hedge. Potential put play, small size.

XBI SPDR S&P Biotech ETF

Trade Overview

Capital Trend

News

Comments